How it works
Progesterone is synthesised from cholesterol in the corpus luteum following ovulation and, at higher concentrations, in the placenta during pregnancy. It binds two nuclear isoforms, PR-A and PR-B, to regulate gene transcription in uterine, mammary, and neural tissues.2 Beyond reproduction, progesterone is a precursor steroid for cortisol, aldosterone, and testosterone, and supports myelin synthesis in the peripheral nervous system.2
The neurological effects of progesterone are largely explained by its rapid conversion in the brain to allopregnanolone, a neuroactive steroid that is a potent positive allosteric modulator of GABA-A receptors.14 Allopregnanolone increases chloride ion flux into neurons, producing sedative and anxiolytic effects that resemble those of benzodiazepine-class compounds. Through this pathway, progesterone shortens sleep onset latency, increases pre-REM intermediate sleep, and reduces nocturnal waking in a dose-dependent manner.1
Progesterone concentrations remain near zero in the follicular phase, rise sharply after ovulation, and peak in the mid-luteal phase before falling ahead of menstruation. These fluctuations modulate GABA-A receptor sensitivity throughout the cycle.2 The mid-luteal peak coincides with the deepest average sleep quality; the pre-menstrual withdrawal correlates with lighter, more disrupted sleep and the elevated anxiety associated with premenstrual syndrome and PMDD.4
Example
An athlete in the late luteal phase notices her sleep is lighter than usual and recovery feels incomplete despite consistent training load and nutrition. She tracks her basal body temperature and cycle phase, recognising this as the pre-menstrual progesterone withdrawal window. Rather than adjusting training volume reactively, she schedules her highest-intensity sessions for the mid-luteal phase, when progesterone peaks and sleep architecture is most restorative.
Cycle-phase awareness turns a hormone-driven sleep disruption from an unexplained bad week into a predictable, manageable variable.
Why it matters
For women of reproductive age, progesterone is the primary reason sleep quality and anxiety levels vary across the menstrual cycle. The late luteal phase drop in progesterone reduces GABA-A modulation at precisely the time when mood stability is most tested. A meta-analysis of nine randomised controlled trials found that oral micronised progesterone improved sleep onset latency by a mean of 7.1 minutes over placebo, with most trials also reporting improved subjective sleep quality.3 The clinical implication is that cycle-phase awareness matters for women managing high training loads or demanding cognitive work.
At perimenopause, the picture sharpens. Progesterone levels become erratic before declining permanently, and the resulting loss of consistent GABA-A modulation accounts for much of the insomnia, anxiety, and irritability widely reported during this transition.43 Oral micronised progesterone is the preferred clinical form for this context: it replicates the hormone's natural metabolite profile, preserves normal sleep architecture, and does not carry the dependency risk associated with synthetic progestogens.3
What does progesterone do in the body?+
Progesterone prepares the uterine lining for embryo implantation, sustains early pregnancy, and modulates the central nervous system through its metabolite allopregnanolone, which activates GABA-A receptors. It also acts as a biochemical precursor for cortisol, aldosterone, and testosterone, and contributes to myelin synthesis in the peripheral nervous system.{{cite:10.3390/ijms222011039}}
How does progesterone affect sleep?+
Progesterone converts in the brain to allopregnanolone, which activates GABA-A receptors and reduces sleep onset latency. A meta-analysis of nine randomised controlled trials reported a mean improvement of 7.1 minutes in sleep onset latency with oral micronised progesterone versus placebo, alongside subjective improvements in sleep quality.{{cite:10.1152/ajpendo.1996.271.4.e763}}{{cite:10.1210/clinem/dgaa873}}
Why does low progesterone cause anxiety and mood changes?+
Low progesterone means low allopregnanolone, reducing positive modulation of GABA-A receptors and raising neural excitability. The relationship between allopregnanolone concentration and mood is an inverted-U: both very low levels and rapid changes in levels can destabilise affect, which is why pre-menstrual and perimenopausal phases both carry elevated anxiety risk.{{cite:10.3390/ph16040520}}
What are normal progesterone levels across the menstrual cycle?+
Progesterone remains near zero in the follicular phase, rises sharply after ovulation, and peaks in the mid-luteal phase before falling ahead of menstruation. During pregnancy, placental production substantially raises circulating concentrations. At menopause, levels return to near-zero and the GABA-A-modulatory effects are lost.{{cite:10.3390/ijms222011039}}{{cite:10.3390/ph16040520}}
